ENPP2 and pulmonary fibrosis: ATX inhibition was shown to attenuate pulmonary fibrosis [29], thus providing the rationale for therapeutic usage of ATX inhibitors, like IOA-289, in cancers characterised by a high degree of fibrosis, such as gastrointestinal cancers.